|
CLDN12 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.559800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.574300E-02 |
| Normal-vs-Stage2 |
1.691850E-02 |
| Normal-vs-Stage3 |
1.033020E-01 |
| Normal-vs-Stage4 |
3.668600E-01 |
| Stage1-vs-Stage2 |
2.517800E-01 |
| Stage1-vs-Stage3 |
9.630800E-01 |
| Stage1-vs-Stage4 |
6.669000E-01 |
| Stage2-vs-Stage3 |
2.981600E-01 |
| Stage2-vs-Stage4 |
2.484600E-01 |
| Stage3-vs-Stage4 |
6.807200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.208300E-02 |
| Normal-vs-AfricanAmerican |
7.873000E-01 |
| Normal-vs-Asian |
1.952240E-01 |
| Caucasian-vs-AfricanAmerican |
3.205800E-01 |
| Caucasian-vs-Asian |
8.541000E-01 |
| AfricanAmerican-vs-Asian |
4.371000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.675900E-03 |
| Normal-vs-Female |
1.544440E-01 |
| Male-vs-Female |
7.094100E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.575800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.952200E-02 |
| Normal-vs-Age(61-80Yrs) |
4.781500E-02 |
| Normal-vs-Age(81-100Yrs) |
2.703200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.996800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.534600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.698600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.078200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.922000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.845400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.582360E-01 |
| Classical-VS-Follicular |
2.735200E-03 |
| Classical-VS-Other |
7.475800E-01 |
| Classical-VS-Normal |
2.516600E-01 |
| Tall-VS-Follicular |
1.818820E-03 |
| Tall-VS-Other |
3.004400E-01 |
| Tall-VS-Normal |
6.589000E-01 |
| Follicular-VS-Other |
5.051600E-01 |
| Follicular-VS-Normal |
1.780050E-03 |
| Other-VS-Normal |
4.311400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.442100E-03 |
| Normal-vs-N1 |
2.815800E-01 |
| N0-vs-N1 |
3.392400E-01 |
|
|
